ATE102480T1 - Multigranulaere tablette mit verzoegerter freisetzung. - Google Patents

Multigranulaere tablette mit verzoegerter freisetzung.

Info

Publication number
ATE102480T1
ATE102480T1 AT87111330T AT87111330T ATE102480T1 AT E102480 T1 ATE102480 T1 AT E102480T1 AT 87111330 T AT87111330 T AT 87111330T AT 87111330 T AT87111330 T AT 87111330T AT E102480 T1 ATE102480 T1 AT E102480T1
Authority
AT
Austria
Prior art keywords
multigranular
delayed
formulation adjuvant
release tablet
sustained
Prior art date
Application number
AT87111330T
Other languages
English (en)
Inventor
Hidenobu Andoh
Sumio Watanabe
Yasuo Miyake
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ATE102480T1 publication Critical patent/ATE102480T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Vending Machines For Individual Products (AREA)
  • Mechanical Pencils And Projecting And Retracting Systems Therefor, And Multi-System Writing Instruments (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT87111330T 1986-08-06 1987-08-05 Multigranulaere tablette mit verzoegerter freisetzung. ATE102480T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61183414A JPH0780754B2 (ja) 1986-08-06 1986-08-06 多顆粒型持続性錠剤
EP87111330A EP0255725B1 (de) 1986-08-06 1987-08-05 Multigranuläre Tablette mit verzögerter Freisetzung

Publications (1)

Publication Number Publication Date
ATE102480T1 true ATE102480T1 (de) 1994-03-15

Family

ID=16135361

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87111330T ATE102480T1 (de) 1986-08-06 1987-08-05 Multigranulaere tablette mit verzoegerter freisetzung.

Country Status (11)

Country Link
EP (1) EP0255725B1 (de)
JP (1) JPH0780754B2 (de)
KR (1) KR950002148B1 (de)
AT (1) ATE102480T1 (de)
CA (1) CA1315680C (de)
DE (1) DE3789258T2 (de)
DK (1) DK175798B1 (de)
ES (1) ES2050653T3 (de)
FI (1) FI96480C (de)
NO (1) NO178134C (de)
PH (1) PH25545A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
DE4122217C2 (de) * 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
WO1995010264A1 (en) * 1993-10-12 1995-04-20 Tokyo Tanabe Company Limited Tablet containing enteric granules
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
FR2795962B1 (fr) 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
JP2004531467A (ja) 2000-11-28 2004-10-14 エフ　エム　シー　コーポレーション 可食性ｐｇａ被覆組成物
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
ES2351249T3 (es) 2001-07-27 2011-02-02 Astellas Pharma Inc. Composición que comprende partículas finas, de liberación sostenida, para comprimidos de disgregación rápida en la cavidad bucal.
FR2837100B1 (fr) * 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1390032A (en) * 1971-08-27 1975-04-09 Sterling Winthrop Group Ltd Pharmaceutical compositions
JPS5873359A (ja) * 1981-10-27 1983-05-02 旭化成株式会社 医薬錠剤の製造方法

Also Published As

Publication number Publication date
FI96480B (fi) 1996-03-29
ES2050653T3 (es) 1994-06-01
DK175798B1 (da) 2005-02-28
CA1315680C (en) 1993-04-06
EP0255725A2 (de) 1988-02-10
NO178134C (no) 1996-01-31
NO178134B (no) 1995-10-23
PH25545A (en) 1991-08-08
DK407287A (da) 1988-02-07
FI96480C (fi) 1996-07-10
FI873407L (fi) 1988-02-07
JPS6339811A (ja) 1988-02-20
EP0255725A3 (de) 1991-01-30
JPH0780754B2 (ja) 1995-08-30
DE3789258T2 (de) 1994-08-11
KR950002148B1 (ko) 1995-03-14
FI873407A0 (fi) 1987-08-05
DK407287D0 (da) 1987-08-05
EP0255725B1 (de) 1994-03-09
DE3789258D1 (de) 1994-04-14
NO873273D0 (no) 1987-08-05
NO873273L (no) 1988-02-08
KR880002510A (ko) 1988-05-09

Similar Documents

Publication Publication Date Title
NO884947D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk doseringsform med kontrollert frigjoerelse.
SE8504720D0 (sv) New drug preparation
PT90049A (pt) Forma de dosagem para administrar um medicamento para terapia humana
NO871277D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler.
ES487151A1 (es) Procedimiento de preparacion de nuevas formas galenicas de administracion de medicamentos por via oral, con liberacion programada
DE3776982D1 (de) Arzneimittel mit gesteuerter absorption.
ATE102480T1 (de) Multigranulaere tablette mit verzoegerter freisetzung.
FI920956A0 (fi) Doseringsform foer administrering av oral hypoglykemisk glipisid.
NO874869D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO882406L (no) Fremgangsmaate for fremstilling av terapeutisk aktive urinstoff- og karbamat-forbindelser.
DE3769707D1 (de) Therapeutisches system mit geregelter wirkstoffabgabe.
NO165922C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av hexahydro-8-hydroxy-2,6-methano-2h-kinolizin-3-(4h)-on og beslektede forbindelser.
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO167797C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt nitrometan.
EP0425298A3 (en) Sustained-release preparation of basic medical agent hydrochloride
NO167287C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-isoxazol-beta-carboliner.
NO168247C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner.
JPS6463521A (en) Trapidyl-containing drug composition, manufacture and related therapeutical use
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO883959L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO873805D0 (no) Medisinsk doseringsanordning for uttoemning av forstoevet medikament for inhaleringsluft.
MY103627A (en) A controlled release pharmaceutical dosage form and a process for preparing same.
NO880841D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO870151D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-pyrimidinamider.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time